Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 143K 124K 114K 107K 201K 13.56M 203K 1.34M 523K 6.64M 538K 527K 23M | P/E Ratio 2022 |
-0.81x | P/E Ratio 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 19.77M 18.19M 17.09M 32.1M 2.17B 32.47M 215M 83.71M 1.06B 86.12M 84.29M 3.68B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | +0.64% | +17.35% | -11.68% | 176B | |
| +0.12% | -0.37% | -18.57% | +27.05% | 148B | |
| +0.14% | -1.19% | -9.63% | -25.53% | 128B | |
| +0.34% | -3.66% | -52.96% | -13.08% | 69.5B | |
| +2.67% | +3.18% | +17.87% | -2.97% | 49.68B | |
| +0.97% | +2.71% | -22.67% | -32.79% | 45.26B | |
| -1.72% | -3.28% | +9.62% | +5.86% | 36.88B | |
| +0.78% | -0.77% | +5.33% | +34.48% | 35.13B | |
| -2.36% | -2.23% | -12.48% | -20.06% | 29.46B | |
| Average | +0.07% | -0.91% | -7.35% | -4.30% | 79.74B | |
| Weighted average by Cap. | +0.10% | -0.65% | -6.36% | -4.24% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.49M 1.37M 1.29M 2.42M 164M 2.45M 16.17M 6.31M 80.08M 6.49M 6.35M 277M | 1.98M 1.7M 1.57M 1.47M 2.77M 187M 2.8M 18.49M 7.21M 91.58M 7.42M 7.26M 317M |
| Net income | -16.08M -13.85M -12.75M -11.97M -22.49M -1.52B -22.75M -150M -58.64M -744M -60.33M -59.05M -2.58B | -29.31M -25.25M -23.24M -21.83M -41M -2.77B -41.48M -274M -107M -1.36B -110M -108M -4.7B |
| Net Debt | 20.53M 17.68M 16.27M 15.29M 28.71M 1.94B 29.04M 192M 74.87M 950M 77.02M 75.39M 3.29B | 22.8M 19.64M 18.08M 16.98M 31.9M 2.16B 32.27M 213M 83.19M 1.06B 85.58M 83.76M 3.66B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
